{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:58:49Z","timestamp":1785441529096,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-026-04415-6","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:34:28Z","timestamp":1785378868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic radiosurgery for spinal cholangiocarcinoma metastases: Clinical outcomes and the role of biologically effective dose thresholds"],"prefix":"10.1007","volume":"49","author":[{"given":"Juan J.","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F.","family":"Al Gharyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke S.","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deya","family":"Abu-Reesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Ustrzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armine","family":"Tayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erqi L.","family":"Pollom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atman","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Hayden","family":"Gephart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"9935","key":"4415_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ, Cholangiocarcinoma (2014) Lancet 383(9935):2168\u20132179. https:\/\/doi.org\/10.1016\/S0140-6736(13)61903-0","journal-title":"Lancet"},{"issue":"9","key":"4415_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9):557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4415_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.20524\/aog.2025.0951","volume":"38","author":"R Medha","year":"2025","unstructured":"Medha R, Sreeram PSS, Daaboul O et al (2025) Forty-five-year trends in intra- and extrahepatic cholangiocarcinoma: sex- and race-based insights. Ann Gastroenterol 38(2):214\u2013220. https:\/\/doi.org\/10.20524\/aog.2025.0951","journal-title":"Ann Gastroenterol"},{"issue":"Suppl 1","key":"4415_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G (2019) Cholangiocarcinoma: epidemiology and risk factors. Liver Int 39(Suppl 1):19\u201331. https:\/\/doi.org\/10.1111\/liv.14095","journal-title":"Liver Int"},{"issue":"49","key":"4415_CR5","doi-asserted-by":"publisher","first-page":"e18191","DOI":"10.1097\/MD.0000000000018191","volume":"98","author":"R Cheng","year":"2019","unstructured":"Cheng R, Du Q, Ye J, Wang B, Chen Y (2019) Prognostic value of site-specific metastases for patients with advanced intrahepatic cholangiocarcinoma: a SEER database analysis. Med (Baltim) 98(49):e18191. https:\/\/doi.org\/10.1097\/MD.0000000000018191","journal-title":"Med (Baltim)"},{"key":"4415_CR6","doi-asserted-by":"publisher","first-page":"7195373","DOI":"10.1155\/2020\/7195373","volume":"2020","author":"F Hahn","year":"2020","unstructured":"Hahn F, M\u00fcller L, M\u00e4hringer-Kunz A et al (2020) Distant metastases in patients with intrahepatic cholangiocarcinoma: does location matter? a retrospective analysis of 370 patients. J Oncol 2020:7195373. https:\/\/doi.org\/10.1155\/2020\/7195373","journal-title":"J Oncol"},{"issue":"18","key":"4415_CR7","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2217\/fon-2018-0846","volume":"15","author":"X Yan","year":"2019","unstructured":"Yan X, Wang P, Zhu Z et al (2019) Site-specific metastases of intrahepatic cholangiocarcinoma and its impact on survival: a population-based study. Future Oncol 15(18):2125\u20132137. https:\/\/doi.org\/10.2217\/fon-2018-0846","journal-title":"Future Oncol"},{"issue":"14","key":"4415_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273\u20131281. https:\/\/doi.org\/10.1056\/NEJMoa0908721","journal-title":"N Engl J Med"},{"issue":"1","key":"4415_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11060-014-1463-9","volume":"119","author":"UK Chang","year":"2014","unstructured":"Chang UK, Kim MS, Han CJ, Lee DH (2014) Clinical result of stereotactic radiosurgery for spinal metastasis from hepatocellular carcinoma: comparison with conventional radiation therapy. J Neurooncol 119(1):141\u2013148. https:\/\/doi.org\/10.1007\/s11060-014-1463-9","journal-title":"J Neurooncol"},{"issue":"16","key":"4415_CR10","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/cancers16162800","volume":"16","author":"R Houston","year":"2024","unstructured":"Houston R, Desai S, Takayanagi A et al (2024) A multidisciplinary update on treatment modalities for metastatic spinal tumors with a surgical emphasis: a literature review and evaluation of the role of artificial intelligence. Cancers (Basel) 16(16):2800. https:\/\/doi.org\/10.3390\/cancers16162800","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4415_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3171\/2014.10.SPINE14252","volume":"22","author":"BG Bate","year":"2015","unstructured":"Bate BG, Khan NR, Kimball BY, Gabrick K, Weaver J (2015) Stereotactic radiosurgery for spinal metastases with or without separation surgery. J Neurosurg Spine 22(4):409\u2013415. https:\/\/doi.org\/10.3171\/2014.10.SPINE14252","journal-title":"J Neurosurg Spine"},{"key":"4415_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2025.03.001","author":"KN Chou","year":"2025","unstructured":"Chou KN, Park DJ, Hori YS et al (2025) Primary stereotactic body radiation therapy for breast cancer spinal metastases. Clin Breast Cancer. https:\/\/doi.org\/10.1016\/j.clbc.2025.03.001. S1526-8209(25)00047\u2009\u2013\u20093","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"4415_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s11060-024-04821-0","volume":"170","author":"S Adida","year":"2024","unstructured":"Adida S, Taori S, Donohue JK et al (2024) Stereotactic radiosurgery for patients with spinal metastases from prostate cancer. J Neurooncol 170(3):631\u2013639. https:\/\/doi.org\/10.1007\/s11060-024-04821-0","journal-title":"J Neurooncol"},{"issue":"7","key":"4415_CR14","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1016\/j.cllc.2024.05.007","volume":"25","author":"KN Chou","year":"2024","unstructured":"Chou KN, Park DJ, Hori YS et al (2024) Primary stereotactic body radiotherapy for spinal bone metastases from lung adenocarcinoma. Clin Lung Cancer 25(7):e337\u2013e347. https:\/\/doi.org\/10.1016\/j.cllc.2024.05.007","journal-title":"Clin Lung Cancer"},{"key":"4415_CR15","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1016\/j.wneu.2024.02.102","volume":"185","author":"S Taori","year":"2024","unstructured":"Taori S, Adida S, Tang A et al (2024) Stereotactic radiosurgery for patients with spinal metastases from thyroid cancer: a 20-year experience. World Neurosurg 185:e653\u2013e661. https:\/\/doi.org\/10.1016\/j.wneu.2024.02.102","journal-title":"World Neurosurg"},{"issue":"2","key":"4415_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11060-020-03522-8","volume":"148","author":"O Gjyshi","year":"2020","unstructured":"Gjyshi O, Boyce-Fappiano D, Pezzi TA et al (2020) Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol 148(2):327\u2013334. https:\/\/doi.org\/10.1007\/s11060-020-03522-8","journal-title":"J Neurooncol"},{"issue":"3","key":"4415_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/liv.12260","volume":"34","author":"Y Choi","year":"2014","unstructured":"Choi Y, Kim J, Lee I, Seong J (2014) Dose escalation using helical tomotherapy improves local control in spine metastases from primary hepatic malignancies. Liver Int 34(3):462\u2013468. https:\/\/doi.org\/10.1111\/liv.12260","journal-title":"Liver Int"},{"issue":"1","key":"4415_CR18","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2016.9.FOCUS16369","volume":"42","author":"Y Yamada","year":"2017","unstructured":"Yamada Y, Katsoulakis E, Laufer I et al (2017) The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus 42(1):E6. https:\/\/doi.org\/10.3171\/2016.9.FOCUS16369","journal-title":"Neurosurg Focus"},{"issue":"4","key":"4415_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349 PMID: 18313558","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"4415_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijrobp.2015.04.050","volume":"93","author":"C Tang","year":"2015","unstructured":"Tang C, Hess K, Bishop AJ et al (2015) Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: secondary analysis of mature prospective trials. Int J Radiat Oncol Biol Phys 93(1):118\u2013125. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4415_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/clon.2001.9221","volume":"13","author":"B Jones","year":"2001","unstructured":"Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA (2001) The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) 13(2):71\u201381. https:\/\/doi.org\/10.1053\/clon.2001.9221","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"6","key":"4415_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.5603\/RPOR.a2021.0099","volume":"26","author":"RO Kowalchuk","year":"2021","unstructured":"Kowalchuk RO, Cousins D, Spencer KM et al (2021) Local control of 1\u20135 fraction radiotherapy regimens for spinal metastases: an analysis of the impacts of biologically effective dose and primary histology. Rep Pract Oncol Radiother 26(6):883\u2013891. https:\/\/doi.org\/10.5603\/RPOR.a2021.0099","journal-title":"Rep Pract Oncol Radiother"},{"key":"4415_CR23","doi-asserted-by":"publisher","first-page":"100584","DOI":"10.1016\/j.ctro.2023.100584","volume":"39","author":"M Terlizzi","year":"2023","unstructured":"Terlizzi M, Limkin E, Sellami N, Louvel G, Blanchard P (2023) Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature. Clin Transl Radiat Oncol 39:100584. https:\/\/doi.org\/10.1016\/j.ctro.2023.100584","journal-title":"Clin Transl Radiat Oncol"},{"key":"4415_CR24","first-page":"1","volume":"14","author":"ICRU","year":"2017","unstructured":"ICRU (2017) ICRU report 91, prescribing, recording, and reporting of stereotactic treatments with small photon beams. J ICRU 14:1\u2013160","journal-title":"J ICRU"},{"issue":"6","key":"4415_CR25","doi-asserted-by":"publisher","first-page":"e13932","DOI":"10.1002\/acm2.13932","volume":"24","author":"D Conlon","year":"2023","unstructured":"Conlon D, Connolly J, Galal M, Ahmed I, Foley M, Kleefeld C (2023) Analysis of CyberKnife intracranial treatment plans using ICRU 91 dose reporting: A retrospective study. J Appl Clin Med Phys 24(6):e13932. https:\/\/doi.org\/10.1002\/acm2.13932","journal-title":"J Appl Clin Med Phys"},{"key":"4415_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7150\/jca.1.80","volume":"1","author":"CM Costelloe","year":"2010","unstructured":"Costelloe CM, Chuang HH, Madewell JE, Ueno NT (2010) Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80\u201392. https:\/\/doi.org\/10.7150\/jca.1.80","journal-title":"J Cancer"},{"issue":"Suppl 1","key":"4415_CR27","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl 1):122S\u201350S. https:\/\/doi.org\/10.2967\/jnumed.108.057307","journal-title":"J Nucl Med"},{"issue":"16","key":"4415_CR28","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","volume":"16","author":"I Thibault","year":"2015","unstructured":"Thibault I, Chang EL, Sheehan J et al (2015) Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the spine response assessment in neuro-oncology (SPINO) group. Lancet Oncol 16(16):e595\u2013603. https:\/\/doi.org\/10.1016\/S1470-2045(15)00166-7","journal-title":"Lancet Oncol"},{"key":"4415_CR29","unstructured":"National Cancer Institute (US). Common Terminology Criteria for Adverse Events (CTCAE) Version 6.0 [Internet]. Bethesda (MD): National Cancer Institute (2025) Jul 22. Available from: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v6.pdf"},{"issue":"1","key":"4415_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra P, Pandey CM, Singh U, Gupta A, Sahu C, Keshri A (2019) Descriptive statistics and normality tests for statistical data. Ann Card Anaesth 22(1):67\u201372. https:\/\/doi.org\/10.4103\/aca.ACA_157_18","journal-title":"Ann Card Anaesth"},{"issue":"12","key":"4415_CR31","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s12094-023-03188-4","volume":"25","author":"R Ci\u00e9rvide","year":"2023","unstructured":"Ci\u00e9rvide R, Hernando O, L\u00f3pez M et al (2023) Stereotactic body radiation therapy (SBRT) for spinal metastases: 12 years of a single center experience. Clin Transl Oncol 25(12):3395\u20133404. https:\/\/doi.org\/10.1007\/s12094-023-03188-4","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"4415_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00066-018-1367-2","volume":"195","author":"J Lee","year":"2019","unstructured":"Lee J, Yoon WS, Koom WS, Rim CH (2019) Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review. Strahlenther Onkol 195(2):93\u2013102. https:\/\/doi.org\/10.1007\/s00066-018-1367-2","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"4415_CR33","doi-asserted-by":"publisher","first-page":"101412","DOI":"10.1016\/j.adro.2023.101412","volume":"9","author":"H Yankey","year":"2023","unstructured":"Yankey H, Ruth KJ, Dotan E, Reddy S, Meyer JE (2023) Survival and toxicity in patients with unresectable or inoperable biliary tract cancers with ablative radiation therapy versus nonablative chemoradiation. Adv Radiat Oncol 9(4):101412. https:\/\/doi.org\/10.1016\/j.adro.2023.101412","journal-title":"Adv Radiat Oncol"},{"key":"4415_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.wneu.2016.04.026","volume":"91","author":"CR Goodwin","year":"2016","unstructured":"Goodwin CR, Yanamadala V, Ruiz-Valls A et al (2016) A systematic review of metastatic hepatocellular carcinoma to the spine. World Neurosurg 91:510\u2013517e4. https:\/\/doi.org\/10.1016\/j.wneu.2016.04.026","journal-title":"World Neurosurg"},{"issue":"4","key":"4415_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12029-017-0009-8","volume":"48","author":"R Bhatia","year":"2017","unstructured":"Bhatia R, Ravulapati S, Befeler A, Dombrowski J, Gadani S, Poddar N (2017) Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management-single-center experience. Erratum in. J Gastrointest Cancer 48(4):390. https:\/\/doi.org\/10.1007\/s12029-017-0009-8","journal-title":"J Gastrointest Cancer"},{"key":"4415_CR36","doi-asserted-by":"publisher","first-page":"100710","DOI":"10.1016\/j.jbo.2025.100710","volume":"54","author":"F N\u00e4gler","year":"2025","unstructured":"N\u00e4gler F, Seiler I, Sch\u00e4fer S et al (2025) Stereotactic body radiotherapy for spine and non-spine bone metastases in prostate carcinoma - a multicenter cohort analysis. J Bone Oncol 54:100710","journal-title":"J Bone Oncol"},{"key":"4415_CR37","doi-asserted-by":"publisher","first-page":"111485","DOI":"10.1016\/j.radonc.2026.111485","volume":"14","author":"F N\u00e4gler","year":"2026","unstructured":"N\u00e4gler F, Sch\u00e4fer S, Seiler I et al (2026) Outcomes of stereotactic body radiotherapy for bone oligometastases in older patients - a European multicenter cohort study. Radiother Oncol 14:111485. https:\/\/doi.org\/10.1016\/j.radonc.2026.111485","journal-title":"Radiother Oncol"},{"issue":"1","key":"4415_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12885-025-13655-6","volume":"25","author":"A Pratapneni","year":"2025","unstructured":"Pratapneni A, Klebaner D, Soltys SG et al (2025) Single- versus multi-fraction spine stereotactic radiosurgery (ALL-STAR) for patients with spinal metastases: a randomized phase III trial protocol. BMC Cancer 25(1):323. https:\/\/doi.org\/10.1186\/s12885-025-13655-6","journal-title":"BMC Cancer"},{"key":"4415_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.radonc.2018.11.015","volume":"132","author":"TB Brunner","year":"2019","unstructured":"Brunner TB, Blanck O, Lewitzki V et al (2019) Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. Radiother Oncol 132:42\u201347","journal-title":"Radiother Oncol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-026-04415-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:04:56Z","timestamp":1785438296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-026-04415-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4415"],"URL":"https:\/\/doi.org\/10.1007\/s10143-026-04415-6","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board approved with a waiver of informed consent.","order":1,"name":"Ethics","label":"Ethical considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":6,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"498"}}